Full Press Release Details
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA.
IRD
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
Key Takeaway: Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+140%
120-day peak, hindsight
Typical move
6.3%
average across 11 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
APX3330
Phase 2 · Diabetic Retinopathy